Decidual/trophoblast PRL-related protein (d/tPRP) is a member of the PRL gene family and is dually expressed in uterine and placental tissues in a highly coordinated pattern during pregnancy. In the present study, we describe the isolation and characterization of the d/tPRP gene. A DASH II Wistar-Kyoto rat genomic library was screened with a labeled d/tPRP complementary DNA, resulting in the isolation of two phage clones, ] and . RGLd-41 alone was found to contain the fulllength d/tPRP gene and was used for subsequent analyses. T HE ESTABLISHMENT and maintenance of pregnancy in the female reproductive tract requires extensive remodeling of the uterine endometrium and development of the placenta. In some species, including the rat and human, uterine stromal cells differentiate into a specialized structure, referred to as the decidua (1-3). Together, the decidua and placenta provide the conduit through which the fetus gains access to nutrients and eliminates wastes. Appropriate development of these tissues is essential for reproductive success.
T HE ESTABLISHMENT and maintenance of pregnancy in the female reproductive tract requires extensive remodeling of the uterine endometrium and development of the placenta. In some species, including the rat and human, uterine stromal cells differentiate into a specialized structure, referred to as the decidua (1) (2) (3) . Together, the decidua and placenta provide the conduit through which the fetus gains access to nutrients and eliminates wastes. Appropriate development of these tissues is essential for reproductive success.
The functions of the decidua and placenta are probably mediated in part by their production of hormones and cytokines. In the rat, at least nine different genes, structurally related to PRL, are expressed by uterine decidual cells and/or trophoblast cells of the chorioallantoic placenta in a highly coordinated pattern during pregnancy (4) . Decidual/ trophoblast PRL-related protein (d/tPRP) is an example of a subset of PRL family members that is dually expressed in both decidual and trophoblast cell types (5) (6) (7) . Some members of the PRL family use the PRL receptor signaling system and mimic the actions of PRL, whereas other members of the family activate apparently novel signaling pathways and possess apparently novel biological activities (4) . d/tPRP falls into this latter category. It does not activate PRL receptor signaling pathways; however, d/tPRP does interact with heparin-containing molecules, and it increases the tumorigenicity of Chinese hamster ovary cells (8) . The mechanisms through which the expression patterns and actions of d/tPRP facilitate the establishment and maintenance of pregnancy are yet to be resolved.
In this report, we present information on the isolation and characterization of the d/tPRP gene. We show that d/tPRP possesses a unique six-exon, five-intron gene structure and that regulatory DNA associated with the d/tPRP gene directs decidua-and trophoblast-specific expression.
Materials and Methods Reagents
FBS and donor horse serum were purchased from JRH Bioscience (Lenexa, KS). Reagents for PAGE were purchased from Bio-Rad (Hercules, CA). The chemiluminescent detection system was obtained from Amersham Life Science (Arlington Heights, IL). The streptavidin-biotin immunoperoxidase kit and diaminobenzidine were obtained from Vector Laboratories (Burlingame, CA). Dispase was purchased from Boehringer Mannheim (Indianapolis, IN). All restriction enzymes, polymerases, and DNA ligases were purchased from New England Biolabs (Beverly, MA). The GH 3 pituitary tumor and L929 cell lines and a Rous sarcoma virus promoter-␤-galactosidase (RSV-␤GAL) reporter plasmid were obtained from American Type Culture Collection (Rockville, MD). Transformation-competent Sure bacterial cells, pBluescript SK ϩ , the Flash Nonradioactive Gene Mapping kit, and a rat genomic library were acquired from Stratagene (La Jolla, CA). Oligonucleotide probes were synthesized by the University of Kansas Medical Center Biotechnology Support Facility (Kansas City, KS). DNA extraction kits were purchased from Qiagen (Chatsworth, CA). Nitrocellulose and nylon membranes were obtained from Schleicher and Schuell (Keene, NH). The pGL-2 basic vector and a RSV promoter-luciferase reporter plasmid were purchased from Promega (Madison, WI). T7 DNA sequencing kits were acquired from U.S. Biochemical (Cleveland, LH). The Advantage Genomic PCR kit was obtained form Clontech (Palo Alto, CA). Radiolabeled nucleotides were purchased from DuPont-New England Nuclear (Boston, MA). TRIzol reagent for RNA extraction, Superscript preamplification kits, Taq polymerase, and Lipofectamine reagent for transfection were obtained from Life Technologies (Gaithersburg, MD). Kits for monitoring ␤GAL activities were acquired from Tropix (Bedford, MA). Unless otherwise noted, all other chemicals and reagents were purchased from Sigma Chemical Co. (St. Louis, MO).
Animals and tissue preparation
Holtzman rats were obtained from Harlan Sprague-Dawley (Indianapolis, IN). The animals were housed in an environmentally controlled facility, with lights on from 0600 -2000 h, and allowed free access to food and water. Timed pregnancies and tissue dissections were performed as previously described (9) . Day 0 of pregnancy was defined by the presence of a copulatory plug or sperm in the vaginal smear. Protocols for the care and use of animals were approved by the University of Kansas animal care and use committee.
Cell cultures
A series of primary cell cultures and cell lines was evaluated for their ability to express d/tPRP and activate d/tPRP promoter/luciferase reporter constructs. Primary decidual cell cultures were established from deciduomal tissue collected from rats on day 7 of pseudopregnancy. Deciduomal tissue was minced, washed three times in Hanks' Balanced Salt Solution, and dispersed in dispase (2.4 U/ml) containing deoxyribonuclease I (80 U/ml) for 1.5 h at 37 C. Dispersed cells were recovered by centrifugation and washed with Hanks' Balanced Salt Solution to remove residual dispase. Cells were then resuspended in DMEM-MCDB 302 culture medium containing 10% FBS and plated at a concentration equivalent to one uterine horn (7-9 ϫ 10 5 cells)/25-cm 2 flask. After 20 h, medium and unattached cells were removed and replaced with fresh medium containing 1% FBS. Primary spongiotrophoblast cultures were established according to previously published procedures (10) and maintained in DMEM culture medium supplemented with 10% FBS. The UI uterine stromal cell line was established (11) essentially as described by Cohen et al. (12) . CUS V2 and CUS V4 uterine stromal cells are immortalized cells derived from rat uterine stroma by transfecting primary cultures with a temperature-sensitive mutant of the simian virus 40 large T antigen (13) . All uterine stromal cell lines were maintained in Ham's F-10-DMEM culture medium supplemented with 10% FBS. The Rcho-1 trophoblast cell line was derived from a rat choriocarcinoma and is capable of differentiating along the trophoblast giant cell lineage (14) . Rcho-1 trophoblast cells were routinely maintained in subconfluent conditions with NCTC-135 culture medium supplemented with 20% FBS, 50 m 2-mercaptoethanol, and 1 mm sodium pyruvate (14) . Rcho-1 cells were induced to differentiate by growing them to near confluence in FBS-supplemented culture medium and then replacing the FBS with 10% horse serum (15, 16) . The HRP-1 trophoendodermal stem cell line, which exhibits both trophoblast and yolk sac attributes (17, 18) , was maintained in RPMI 1640 medium containing 10% FBS. GH 3 pituitary tumor cells (19) were maintained in DMEM culture medium supplemented with 10% FBS, and L929 mouse fibroblast cells were maintained in RPMI 1640 medium containing 10% FBS. All culture media were supplemented with 100 U/ml penicillin and 100 g/ml streptomycin.
Isolation and characterization of the d/tPRP gene
A genomic DNA library generated from liver tissue of 12-week-old male Wistar-Kyoto outbred rats and packaged in the DASH II vector was obtained from Stratagene. The library was screened with a rat d/tPRP complementary DNA (cDNA) as previously described (5) . DNA from positive plaques was amplified and used to inoculate LE 392 Escherichia coli. Phage DNA was extracted from lysates and characterized by restriction mapping and Southern blot hybridization (20) .
Two d/tPRP genomic clones were identified, RGLd-41 and RGLd-42. Oligonucleotides representing either the 5Ј-or 3Ј-end of d/tPRP cDNA were end labeled with T4 polynucleotide kinase and [␥- 32 P]ATP and used to identify clones containing the full-length d/tPRP gene. Genomic DNA was excised with NotI, and a restriction map was generated using partial BamHI digestion (Flash Nonradioactive Gene Mapping kit). Fragments containing d/tPRP exonic DNA (determined by Southern blot hybridization) were subcloned into the BamHI and/or NotI sites of pBluescript SK ϩ , flanked by T7 and T3 promoters. Exon-containing restriction fragments in pBluescript SK ϩ were sequenced by the dideoxy chain termination method (21) using Sequenase and [
35 S]deoxy-ATP. Primers corresponding to the T7 or T3 flanking sequence or internal oligonucleotide primers were used to sequence all exons and exon/intron boundaries. Reaction products were resolved in 6% polyacrylamide urea gels, dried, and exposed to Kodak X-Omat X-ray film. Comparison with the published d/tPRP cDNA sequence confirmed the identity of the d/tPRP genomic clone (5).
Identification of the d/tPRP transcription start sites
The transcription start site of d/tPRP was determined by primer extension analysis, essentially as described by Duckworth et al. (22) . An oligonucleotide complementary to bases ϩ31 to ϩ10 of the d/tPRP cDNA (from ATG) was synthesized and end labeled using T4 polynucleotide kinase and [␥-
32 P]ATP. The labeled primer (final concentration, 10 m) was extracted with phenol-chloroform, precipitated with ethanol, and hybridized with 5 g total RNA from decidua, junctional zone placenta, or spleen. Reverse transcription was performed using a Superscript Preamplification kit. The reaction was stopped by the addition of sample running buffer (98% formamide, 2.5 mm EDTA, 0.1% bromophenol blue, and 0.1% xylene cyanol) and electrophoretically separated on a 6% polyacrylamide-7 m urea sequencing gel. A known DNA sequence was separated on the same gel to indicate the size of the primer-extended product.
Analysis of d/tPRP expression
Western blot analyses for d/tPRP were performed as previously described (8) . Samples were separated by 12.5% PAGE under reducing conditions and transferred to nitrocellulose membranes. Immunoreactive bands were visualized using a chemiluminescent detection system (Arlington Heights, IL).
Tissue and cellular localization of d/tPRP was confirmed by immunocytochemistry using a streptavidin-biotin immunoperoxidase kit for rabbit IgG and the chromagen, diaminobenzidine (7). The immunostained sections were counterstained with hematoxylin. The specificity of the immunoreactions was demonstrated using preimmune serum and preadsorbed antibodies.
Northern blots were performed as previously described (5, 23) . Total RNA was extracted from tissues and cells essentially as described by Chomczynski and Sacchi (24), using TRIzol. Blots were probed with 32 P-labeled d/tPRP cDNA (5) .
RT was performed using 0.5 g oligo(deoxythymidine) primers and 5 g total RNA. The resulting cDNAs were amplified by PCR for 35 cycles with a denaturing temperature of 94 C (1 min), an annealing temperature of 60 C (2 min), and an extension temperature of 72 C (2 min), using a Perkin-Elmer Thermocycler (model 480, Norwalk, CT). Oligonucleotide primers specifically amplified a 342-bp region of the d/tPRP cDNA: upstream primer, 5Ј-CATGGACCTGAACATGAAAA-CATCAAA-3Ј (sense, 325-354; located on exon 4); and downstream primer, 3Ј-GTGACGGATGCACAACTATATAAGATG-5Ј (antisense, 637-666; located on exon 6). The PCR reaction mixture also contained primers that amplified a 244-bp region of rat ␤-actin (25) . ␤-Actin bands were readily detectable on ethidium bromide-stained gels and used to demonstrate equal loading and integrity of the messenger RNA (mRNA) template. Reaction products were fractionated in agarose gels and transferred to nitrocellulose. Southern blots were performed using 32 P-labeled d/tPRP cDNA and visualized on Kodak X-Omat X-ray film (Eastman Kodak, Rochester, NY).
d/tPRP promoter analysis
Cell-specific d/tPRP promoter activation was evaluated in various primary cell cultures and cell lines. PCR was used to amplify 3960 bp of d/tPRP 5Ј-flanking DNA from the 6.9-kilobase (kb) restriction fragment of the d/tPRP genomic clone. The 3960-bp amplified fragment extended to the cytosine residue located 38 bp downstream of the transcription start site and 28 bp upstream of the translation start site (ATG; see Fig. 2 ). The Advantage Genomic PCR kit was used to amplify a promoter fragment using the high fidelity Tth DNA polymerase. PCR primers were designed so the amplified fragment contained a KpnI restriction site at the 5Ј-end and an XhoI site at the 3Ј-end. This allowed directional cloning of the d/tPRP 5Ј-flanking DNA into the KpnI and XhoI sites of the pGL-2 basic, luciferase reporter vector. We will refer to this construct as d/tPRP-luc.
The d/tPRP-luc construct was transiently transfected into the primary cell culture systems and cell lines using a liposome-mediated delivery system. Cells were plated in 35-mm culture dishes (3 ϫ 10 5 ) and transfected with 2 g d/tPRP-luc, RSV-luc (positive control) or pGL-2 basic vector (negative control). RSV-␤GAL (0.5 g) was cotransfected with all constructs and used to correct for transfection efficiency. Primary decidual and primary spongiotrophoblast cells were transfected on the second day of culture; Rcho-1 trophoblast cells were transfected on day 3 of culture, corresponding to the time that cells were exposed to differentiating conditions. Forty-eight hours after transfection, cells were collected, and lysates were prepared via three consecutive cycles of freezing and thawing. Luciferase activity was determined using a luminometer according to the procedure described by Brasier et al. (26) . ␤GAL activity was evaluated using the Galacto-Light kit, and protein concentrations were determined using the protein-dye binding method described by Bradford (27) . Luciferase activities were normalized for transfection efficiency and protein concentration.
Rcho-1 trophoblast cells were also cotransfected with the d/tPRP-luc construct (3 g/ml; 10-fold excess) and pSV 2 neo (0.3 g/ml; a plasmid providing neomycin resistance). Cells were selected for 2 weeks in the presence of geneticin (G418; 250 g/ml) as we previously described (28) . Stably transfected clones were isolated by limiting dilution. Cellular lysates were collected from stably transfected clones at various times during the transition from proliferation to differentiation states and evaluated for luciferase activity as described above.
Results

Isolation and characterization of the d/tPRP genomic clones
Screening of the DASH II rat genomic library with labeled d/tPRP cDNA resulted in the isolation of two phage clones, RGLd-41 (17.7 kb) and RGLd-42 (15.8 kb) . Dot blot analysis revealed that RGLd-41 alone contained the fulllength d/tPRP gene. A restriction map was generated based on a partial digestion with BamHI (Fig. 1) . Complete NotI/ BamHI digestion resulted in the generation of five fragments, ranging from 2.1-6.9 kb in size (Fig. 1) . Southern blots were performed on the resulting digestion products using random primer-labeled d/tPRP cDNA as a probe. Three exon-containing fragments were identified (open boxes in Fig. 1 ) and subcloned into pBluescript SK ϩ for sequencing. The complete d/tPRP cDNA sequence was identified in the RGLd-41 clone, confirming that it was the full-length d/tPRP genomic DNA. All exons and exon/intron boundaries of the d/tPRP gene were sequenced, and all introns exhibited the consensus GT and AG splicing junctions. The exon/intron organization of the d/tPRP gene was determined by aligning d/tPRP cDNA sequence with the corresponding regions of RGLd-41. Sequence alignment revealed that d/tPRP contains six exons and five introns ( Figs. 1 and  2 ). Relative to the other members of the PRL family, d/tPRP contains one additional exon, exon 3 (Fig. 3) . A homologous exon 3 is also present in PRL-like protein-C variant (PLP-Cv) (29) . Exon 3 encodes a region that is also homologous with unique regions of mouse proliferin-related protein (mPRP) (30) , PLP-C (31), and PLP-D (32). However, the genomic structures of these PRL family members have not been characterized. This exon is part of a larger 14-amino acid region that has been termed the aromatic domain because it contains three phenylalanines and one tyrosine (see Fig. 2 ).
Analysis of tissue-and cell-specific d/tPRP expression
We evaluated d/tPRP expression in a variety of tissues to determine whether it was expressed in a tissue-specific manner. RT-PCR analysis demonstrated that d/tPRP was expressed by the decidua and junctional zone of the chorioallantoic placenta (Fig. 4) . A weaker d/tPRP signal was also observed in the labyrinth zone, but probably resulted from junctional zone contamination. In support of this contention, d/tPRP expression was not detectable in labyrinthine trophoblast by in situ or immunocytochemical analyses (7) .
A primary decidual cell culture system was established and evaluated for its ability to express d/tPRP. Northern blot analysis revealed that d/tPRP mRNA increased until day 3 of culture and was maintained until day 5 (Fig. 5, upper panel) . Immunoreactive d/tPRP increased from days 1-3 of culture, as demonstrated by Western blot (Fig. 5, lower panel) and immunocytochemical analyses (Fig. 6) . In vivo, d/tPRP immunoreactivity was localized predominantly to the antimesometrial region of the decidua (Fig. 6d) .
RT-PCR was used to identify other cell culture models that express d/tPRP (Fig. 7) . In addition to the primary decidual cell culture, d/tPRP expression was monitored in primary spongiotrophoblast culture, the Rcho-1 trophoblast cell line, several uterine stromal cell lines (CUS V2, CUS V4, and UI), L929 mouse fibroblasts, HRP-1 trophoendodermal cells, and GH 3 pituitary tumor cells. Only the primary decidual cells, primary spongiotrophoblast cells, and differentiated (day 9) Rcho-1 trophoblast cells were capable of expressing detectable levels of d/tPRP mRNA. Collectively, these results indicate that d/tPRP is expressed in both a cell-specific and differentiation-dependent manner.
Analysis of the d/tPRP transcription start site
Primer extension analysis was used to identify the d/tPRP transcription start site in decidual tissue and junctional zone placenta. Decidual tissue contained one d/tPRP transcription start site located 65 bases upstream of the translation start site (ATG; Fig. 8 ). In contrast, the placenta had several apparent transcription start sites between 61-66 bases upstream of the translation start site (Fig. 8) . Spleen RNA served as a negative control and had no primer-extended products. The sequence of the proximal promoter revealed a consensus TATA box (TATATAA) at positions Ϫ28 to Ϫ22 relative to the transcription start site (Fig. 2, underlined and shaded) .
Analysis of the d/tPRP promoter
The d/tPRP-luc construct was transiently transfected into a variety of cell lines to determine whether the 5Ј-flanking DNA associated with the d/tPRP gene was capable of directing tissue-specific expression of the luciferase reporter. The results depicted in Fig. 9 demonstrate that 3960 bp of d/tPRP 5Ј-flanking DNA promoted a 60-fold induction of the luciferase reporter relative to the empty pGL-2 vector in primary decidual cells. Lower levels of d/tPRP promoter activity were also detected in CUS V4 and UI uterine stromal cell lines (Fig. 9, upper panel) . Similarly, the 3960-bp d/tPRP promoter was able to drive reporter expression in Rcho-1 trophoblast cells and the spongiotrophoblast primary culture (Fig. 9 , lower panel; 700-and 400-fold induction over pGL-2, (Fig. 10) . d/tPRP-Rcho-3 luciferase activity increased 95-fold between days 2-13 of culture.
Discussion
d/tPRP is one of a cluster of genes located on chromosome 17 of the rat that are related to PRL. These genes are expressed in a coordinated pattern by the anterior pituitary, decidua, and/or placenta during pregnancy. In this report, we have isolated and characterized the d/tPRP gene and provided insight into the cell-specific nature of its expression. The d/tPRP gene exhibits two interesting characteristics: 1) it possesses an atypical exon/intron organization; and 2) it is dually expressed in both maternal and extraembryonic cell types.
Inclusion in the PRL gene family is largely based on structural relationships among the members. Sequence analysis of the original d/tPRP cDNA placed it in the PRL family (5) . Among the many striking similarities of members of the PRL gene family is their exon/intron organization. The PRL gene has retained a characteristic five-exon/four-intron configuration across all species where a structure has been reported (33) . Data for other members of the PRL family, including placental lactogens (PLs), PRL-like proteins, and PRL-related proteins, are less abundant. Nonetheless, bovine PL, mouse PL-II, and mouse proliferin contain a similar five-exon/fourintron organization (34 -36) . d/tPRP exhibits a distinctive variation from this common alignment and represents an exonic structure likely to be characteristic of a subset of PRL family members referred to as the PLP-C subfamily. The PLP-C subfamily includes PLP-C, PLP-Cv, PLP-D, and d/tPRP (5, 29, 31, 32) . Each constituent of this subfamily shows considerable overall homology and contains a unique segment of amino acids that are rich in aromatic residues, which is not present in other members of the PRL family. PRL gene structure. This unique exon 3 encodes a region rich in aromatic amino acids. We hypothesize that PLP-C and PLP-D also exhibit a six-exon/five-intron organization similar to those of PLP-Cv and d/tPRP. A member of the mouse PRL family, mPRP, although showing limited overall homology to the PLP-C subfamily, does contain the aromaticrich domain characteristic of the PLP-C subfamily (30) . Although the mPRP gene has not been cloned, we postulate that its aromatic-rich region may also be encoded by an additional exon. Previously, this similarity led us to speculate that members of the PLP-C subfamily may possess biological activities similar to those of proliferin-related protein, a potent antiangiogenic factor (8, 37) . Initial experimentation has not supported a role of d/tPRP in the modulation of angiogenesis in the uteroplacental environment (8) . Thus, inclusion of the aromatic domain in a protein structure does not appear to be solely responsible for instilling endothelial celltargeted actions. The availability of the d/tPRP gene provides us with a necessary prerequisite for the implementation of additional molecular and transgenic strategies directed toward understanding the role of d/tPRP in the physiology of pregnancy in the rat.
The . However, in contrast to d/tPRP, PLP-B is expressed at relatively low levels in decidua, and within the chorioallantoic placenta its expression is restricted to spongiotrophoblast cells (38 -40) . Analysis of regulatory mechanisms controlling cell-specific gene expression is facilitated by the availability of in vitro strategies. In the present report, we demonstrated the usefulness of primary culture systems for decidual and spongiotrophoblast cells and the value of the Rcho-1 trophoblast cell line. The latter paradigm represents a valuable method of dissecting regulatory mechanisms controlling trophoblast giant cell-specific gene expression (41) . The three cell culture models exhibit characteristics that reflect the three cell types capable of d/tPRP expression in situ. Each of these cell populations was shown in vitro to express d/tPRP and to specifically activate a 3960-bp d/tPRP promoter. Modest d/tPRP promoter activation was also seen in two uterine stromal cell lines (UI and CUS V4). Although these cell lines show minimal endogenous d/tPRP expression, they may represent a stem cell population with some potential to differentiate into decidual cells. Initial attempts to induce an antimesometrial decidual cell phenotype after progesterone and/or PGE 2 treatment of the uterine stromal cell lines have proven unsuccessful (Orwig, K. E., and M. J. Soares, unpublished observations). Rcho-1 trophoblast cells, which exhibit controlled and robust trophoblast giant cell differentiation, activated the 3960-bp d/tPRP promoter in a differentiationdependent manner. Using a similar experimental paradigm, the PL-I and cholesterol side-chain cleavage cytochrome P450 promoters were previously shown to be transcriptionally activated during trophoblast giant cell differentiation (28, 42, 43) .
Regulatory mechanisms controlling the expression of decidua-and trophoblast-specific genes are just beginning to be elucidated. In the present report, we showed that regions located within 4 kb upstream of the d/tPRP gene are capable of specifically directing reporter gene expression to decidual, spongiotrophoblast, and trophoblast giant cells. It is likely that at least some of the regulatory elements controlling decidua-, spongiotrophoblast-, or trophoblast giant cellspecific expression will be differentially located within the 3960-bp d/tPRP promoter.
Decidual cell-specific promoter analyses have been limited to studies on human insulin-like growth factor binding protein-1, human PRL, and rat d/tPRP genes. The insulin-like growth factor binding protein-1 gene is regulated in part via the interaction of the Sp3 protein with cis-elements located between Ϫ2.8 to Ϫ2.6 kb of its 5Ј-flanking DNA (44). Decidual expression of PRL is directed by a 3-kb regulatory region located approximately 6 kb upstream of the pituitary transcription start site (45) (46) (47) . This decidual regulatory region is distinct from the region controlling pituitary PRL gene expression (46, 47) . Progesterone and PGE 2 are activators of pathways controlling decidualization (1, (47) (48) (49) (50) (51) and may also activate transcription of decidual-specific genes. Distinct expression patterns for a few DNA-binding proteins, including the basic helix-loop-helix transcription factor (bHLH) Hed/Thing-2/d-HAND (52) (53) (54) , Wilms' tumor-1 (55) , and the retinoid X receptor-␣ (56), suggest the existence of additional candidate regulators controlling decidualiza- tion and decidual cell-specific gene expression. The involvement of any of these factors or regulatory mechanisms in the control of decidua-specific d/tPRP gene expression is currently being evaluated.
d/tPRP expression in the placenta is restricted to trophoblast giant cells and spongiotrophoblast cells. The Rcho-1 trophoblast cell line has proven useful in the identification of at least some regulatory mechanisms controlling trophoblast giant cell-specific gene expression. AP-1, GATA, and E-box regulatory elements and their respective activators, fos, jun, GATA-2, GATA-3, and the bHLH transcription factor, Hxt/Thing-1/eHAND, have been implicated in transcriptional control of the trophoblast giant cell PL-I gene (42, 52, 57) . Hxt/Thing-1/eHAND has also been postulated to direct differentiation along the trophoblast giant cell lineage (52). Calzonetti and colleagues (58) used a transgenic strategy to identify a 340-bp regulatory region that is essential for targeting the 4311 gene to spongiotrophoblast cells. This region contains E-boxes that may interact with a bHLH transcription factor, Mash-2, which was previously shown to be essential for development of the spongiotrophoblast cell lineage (59) . Whether similar regulatory mechanisms are involved in trophoblast giant cell-and spongiotrophoblast-specific d/tPRP gene expression remain to be determined. In summary, we have demonstrated that the d/tPRP gene is organized in a novel exon/intron arrangement and that the d/tPRP promoter directs cell type-specific and differentiation-dependent expression. Further evaluation of the d/tPRP promoter will facilitate the identification of cisacting elements and trans-acting factors required for decidual-and trophoblast-specific gene expression and the molecular mechanisms controlling decidual and trophoblast differentiation.
